Clinical Trial: Rinvoq 45 mg Brings ‘Rapid Resolution’ of Crohn’s Disease Symptoms
source: shutterstock.com

Clinical Trial: Rinvoq 45 mg Brings ‘Rapid Resolution’ of Crohn’s Disease Symptoms

Patients with moderate to severe Crohn’s disease have found quick relief from abdominal pain and stool frequency during the first week of induction therapy according to data analysis published in…

Continue Reading Clinical Trial: Rinvoq 45 mg Brings ‘Rapid Resolution’ of Crohn’s Disease Symptoms
Investigational Treatment for ADPKD Earns FDA’s Orphan Drug Designation
source: pixabay.com

Investigational Treatment for ADPKD Earns FDA’s Orphan Drug Designation

Approximately 540,000 individuals in the United States have been diagnosed with autosomal dominant polycystic kidney disease (ADPKD). The disease causes persistent and rapidly accumulating cysts to grow in the patient’s…

Continue Reading Investigational Treatment for ADPKD Earns FDA’s Orphan Drug Designation
Is the CDC Botching its RSV Vaccine Rollout?
source: shutterstock.com

Is the CDC Botching its RSV Vaccine Rollout?

  • Post author:
  • Post category:RSV

Last fall, a new vaccine for respiratory syncytial virus (RSV) intended for pregnant people was made available to the public. Physician Sarah Turner, who was used to getting some pushback…

Continue Reading Is the CDC Botching its RSV Vaccine Rollout?
Researchers Discover ‘Super Minigene’ that Helps Find Potential Therapies for Spinal Muscular Atrophy
source: shutterstock.com

Researchers Discover ‘Super Minigene’ that Helps Find Potential Therapies for Spinal Muscular Atrophy

For decades researchers have had to isolate segments of genes in order to study them. They called the isolated gene a “mini gene.” Ravindra Singh, a biomedical science professor at…

Continue Reading Researchers Discover ‘Super Minigene’ that Helps Find Potential Therapies for Spinal Muscular Atrophy
Gene Therapy Led to “Robust Microdystrophin Expression” in Duchenne Muscular Dystrophy Patient
source: pixabay.com

Gene Therapy Led to “Robust Microdystrophin Expression” in Duchenne Muscular Dystrophy Patient

Duchenne muscular dystrophy (DMD) is an inherited disease that weakens a child’s muscles and eventually spreads throughout the child’s body. DMD is caused by mutations in the gene that helps…

Continue Reading Gene Therapy Led to “Robust Microdystrophin Expression” in Duchenne Muscular Dystrophy Patient
First Treatment Approved for Nonalcoholic Steatohepatitis Liver Scarring
source: shutterstock.com

First Treatment Approved for Nonalcoholic Steatohepatitis Liver Scarring

According to a press release from the US Food and Drug Administration (FDA), the agency has approved the medication resmetirom (marketed as Rezdiffra) as the first-ever treatment intended to treat…

Continue Reading First Treatment Approved for Nonalcoholic Steatohepatitis Liver Scarring
Doctors Transplant Genetically Edited Pig Kidney Into 62-Year-Old Man with End-Stage Kidney Disease
source: shutterstock.com

Doctors Transplant Genetically Edited Pig Kidney Into 62-Year-Old Man with End-Stage Kidney Disease

Over 100,000 individuals living in the U.S. are on a waiting list for an organ transplant. An average of 17 people die each day while waiting for a donor organ.…

Continue Reading Doctors Transplant Genetically Edited Pig Kidney Into 62-Year-Old Man with End-Stage Kidney Disease
Scientists Find Potential Treatment Approach for FTD and ALS
luvqs / Pixabay

Scientists Find Potential Treatment Approach for FTD and ALS

According to a recent article in MedicalXpress, scientists have discovered a possible method of treating amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The study was also published in Science…

Continue Reading Scientists Find Potential Treatment Approach for FTD and ALS
Eosinophilic Esophagitis Patients Are Seeing Improved Treatment Options
Photo courtesy of Towfiqu Barbhuiya on Unsplash

Eosinophilic Esophagitis Patients Are Seeing Improved Treatment Options

Recently, the US Food and Drug Administration (FDA) approved a label expansion for the monoclonal antibody dupilumab (marketed as Dupixent) in the treatment of a rare disease called eosinophilic esophagitis…

Continue Reading Eosinophilic Esophagitis Patients Are Seeing Improved Treatment Options
Updated Study Data Suggests Efruxifermin Benefits Stage 2 or 3 MASH
source: shutterstock.com

Updated Study Data Suggests Efruxifermin Benefits Stage 2 or 3 MASH

Over the past few years, Akero Therapeutics has experienced high highs and low lows in its efforts to advance efruxifermin, an investigational drug for people living with metabolic dysfunction-associated steatohepatitis…

Continue Reading Updated Study Data Suggests Efruxifermin Benefits Stage 2 or 3 MASH
Phase 2 Study Evaluates Nizubaglustat for Niemann-Pick Disease type C
Pexels / Pixabay

Phase 2 Study Evaluates Nizubaglustat for Niemann-Pick Disease type C

There are limited therapeutic interventions for those living with Niemann-Pick disease type C (NPC), a rare and progressive genetic disorder. Unfortunately, many people with NPC experience severe and life-threatening complications…

Continue Reading Phase 2 Study Evaluates Nizubaglustat for Niemann-Pick Disease type C
FDA Approves Tyenne, an Actemra Biosimilar for Autoinflammatory Diseases
source: shutterstock.com

FDA Approves Tyenne, an Actemra Biosimilar for Autoinflammatory Diseases

In early March 2024, Tyler Patchen reported that the U.S. Food and Drug Administration (FDA) approved both intravenous and subcutaneous formulations of Tyenne (tocilizumab-aazg) for use in a variety of…

Continue Reading FDA Approves Tyenne, an Actemra Biosimilar for Autoinflammatory Diseases
Investigational Therapy Could be Top of the Line Treatment for MASH
source: shutterstock.com

Investigational Therapy Could be Top of the Line Treatment for MASH

According to a story from Healio, encouraging results from a phase 2 trial could herald a new standard of treatment for metabolic dysfunction-associated steatohepatitis (MASH). The investigational therapy is called…

Continue Reading Investigational Therapy Could be Top of the Line Treatment for MASH
Updated ANCA-Associated Vasculitis Guidelines Aim to Improve Care
source: shutterstock.com

Updated ANCA-Associated Vasculitis Guidelines Aim to Improve Care

According to a story from Medscape, a new set of guidelines from the Kidney Disease: Improving Global Outcomes (KDIGO) aims to improve and update standards of care for antineutrophilic cytoplasmic…

Continue Reading Updated ANCA-Associated Vasculitis Guidelines Aim to Improve Care